Xanax & Alprazolam Pill Identifier: 2mg Bars, Imprints (GG 249, XANAX 2, B707, Kaslol), and Authentic Packaging
Xanax & Alprazolam Pill Identifier: 2mg Bars, Imprints (GG 249, XANAX 2, B707, Kaslol), and Authentic Packaging
A visual tablet identification and counterfeit detection guide for authentic Xanax 2mg bars, 1mg blue ovals, Galenika Kaslol blister packs, and generic imprints.
TABLET IDENTIFICATION GUIDE
EXECUTIVE CLINICAL SUMMARY
Due to widespread illicit counterfeiting, physical visual verification of alprazolam oral tablets is an urgent public health priority. Authentic alprazolam oral tablets display precise physical dimensions, certified debossed alphanumeric imprints, distinct colors based on milligram strength, and tamper-evident pharmaceutical blister packaging. This reference details genuine imprint codes for Pfizer/Upjohn Xanax 2mg bars, Sandoz (GG 249), Breckenridge (B707), Actavis (Y 21), and European Galenika Kaslol 1mg blister packs.
01. Authentic alprazolam imprint codes, shapes, and color matrix
| BRAND / GENERIC | STRENGTH | SHAPE & COLOR | FRONT IMPRINT | BACK IMPRINT |
|---|---|---|---|---|
| Pfizer / Upjohn Xanax® | 2mg | White rectangular bar | XANAX | 2 (multi-scored into 4 quadrants) |
| Sandoz Generic | 2mg | White rectangular bar | GG 249 | Multi-scored (4 sections) |
| Breckenridge Generic | 2mg | Blue rectangular bar | B 7 0 7 | Multi-scored (4 sections) |
| Actavis Generic | 2mg | Yellow rectangular bar | R 0 3 9 (“Schoolbus”) | Multi-scored (4 sections) |
| Galenika Kaslol® | 1mg | Small, round, light blue | Single score line | Smooth, unprinted |
| Greenstone Generic | 1mg | Blue oval | G 3721 | Scored |
| Actavis Generic | 0.5mg | Orange / peach oval | R 0 2 9 | Scored |
02. The anatomy of genuine multi-scored 2mg Xanax bars
Authentic 2mg alprazolam “bars” are rectangular tablets engineered with three deep parallel score lines dividing the tablet into four equal 0.5mg segments. Tablet edges must be cleanly beveled, compression must be dense with zero crumbling, and debossed lettering must exhibit razor-sharp margins.
03. European Galenika Kaslol 1mg blister pack security markers
Authentic Kaslol 1mg manufactured by Galenika d.o.o. is packaged in blister strips of 15 round light-blue tablets. The aluminum foil backing displays dark blue pharmaceutical printing with the Kaslol® brand name, batch serial number, manufacture date, and expiration date. Galenika products are NEVER distributed as loose pills in bulk baggies.
04. Visual red flags for counterfeit fentanyl-laced “pressed” bars
CRITICAL DEA ALERT: ILLICIT PRESSED BARS CONTAINING FENTANYL
The DEA and public health labs report that over 60% of street-sold “Xanax bars” contain illicit fentanyl, designer benzodiazepines (bromazolam, flualprazolam), or lethal synthetic opioids. Critical physical warning signs of fake pressed bars include: chalky residue, powdery edges, inconsistent bar thickness, crumbling when snapped, uneven dye speckling, and crooked imprint lettering.
05. Authorized pharmacy packaging verification standards
Legitimate alprazolam is dispensed exclusively in amber, child-resistant pharmacy vials or sealed manufacturer blister packs carrying an authentic NDC number, dispensing pharmacy address, and patient prescription label.
06. Detailed Receptor Neurobiology & GABA-A Subunit Pharmacology
At the molecular level, Alprazolam (Xanax / Kaslol) functions as a positive allosteric modulator of the gamma-aminobutyric acid type A (GABA-A) receptor complex, the primary inhibitory neurotransmitter system in the mammalian central nervous system. The pentameric GABA-A receptor spans the neuronal cell membrane, typically comprising two alpha (α), two beta (β), and one gamma (γ) subunit arranged around a central chloride ion pore.
Alprazolam (Xanax / Kaslol) binds stereospecifically to the high-affinity allosteric pocket located at the interface of the α and γ2 subunits. Crucially, binding does not directly open the chloride channel in the absence of GABA; rather, it induces a conformational change that increases the affinity of the receptor for endogenous GABA, significantly augmenting the frequency of chloride channel opening bursts.
| GABA-A SUBUNIT ISOFORM | ANATOMICAL DISTRIBUTION | PRIMARY CLINICAL EFFECT | THERAPEUTIC MANIFESTATION |
|---|---|---|---|
| α1 Subunit | Cerebral cortex, cerebellum, thalamus | Sedation, anterograde amnesia, ataxia | Hypnotic effect, sleep latency reduction |
| α2 Subunit | Limbic system, amygdala, striatum | Anxiolysis, emotional tranquility | Suppression of acute panic, fear extinction |
| α3 Subunit | Spinal cord motor neurons, reticular formation | Muscle relaxation, sensorimotor gating | Spasticity reduction, central tone relief |
| α5 Subunit | Hippocampus, temporal lobe circuits | Temporal memory encoding, cognition | Mild cognitive slowing, tolerance onset |
The resulting influx of extracellular chloride ions into the neuronal cytoplasm hyperpolarizes the postsynaptic resting membrane potential from approximately -70 mV to -85 mV. This electrical hyperpolarization elevates the threshold required to fire action potentials, fundamentally quieting hyperactive neural circuits within the amygdalar-cortical anxiety axis.
07. Hepatic Clearance, Renal Impairment & Beers Criteria Safety
Because Alprazolam (Xanax / Kaslol) undergoes extensive oxidative hepatic biotransformation and subsequent phase II conjugation before undergoing renal excretion, therapeutic drug monitoring and dose titrations must be carefully tailored in patients with compromised organ clearance:
| CLINICAL POPULATION | PHARMACOKINETIC ALTERATION | RECOMMENDED DOSING STRATEGY | PRIMARY RISK FACTOR |
|---|---|---|---|
| Hepatic Insufficiency (Child-Pugh A/B) | Decreased clearance, prolonged elimination half-life | Initiate at 50% standard adult dose; monitor hepatic enzymes | Severe medication accumulation, excessive daytime sedation |
| Severe Hepatic Cirrhosis (Child-Pugh C) | Profound metabolic impairment, shunting of portal blood | Contraindicated or strict specialist supervision only | Hepatic encephalopathy precipitation |
| Renal Impairment (CrCl < 30 mL/min) | Impaired clearance of active polar metabolites | Titrate slowly with prolonged inter-dose intervals | Metabolite accumulation, lingering psychomotor slowing |
| Geriatric Patients (≥ 65 Years) | Reduced volume of distribution, lower plasma albumin binding | Maximum initial dose: 50% of adult dose (Beers Criteria) | Ataxia, nocturnal confusion, hip fractures, motor vehicle accidents |
Under the American Geriatrics Society (AGS) Beers Criteria®, central nervous system depressants in this therapeutic class are designated as Potentially Inappropriate Medications (PIMs) in older adults due to heightened pharmacodynamic sensitivity, slower metabolic biotransformation, and markedly increased risk of falls, motor vehicle trauma, and acute delirium. Where clinical indications necessitate treatment, medical guidelines mandate starting at the lowest effective dose for the briefest possible clinical duration.
08. Comprehensive Patient Clinical Safety & Dispensing Checklist
Before initiating therapy or taking each scheduled dose of Alprazolam (Xanax / Kaslol), patients, caregivers, and healthcare providers must review this standardized clinical verification checklist to prevent adverse drug events and dangerous interactions:
PATIENT PRE-ADMINISTRATION SAFETY CRITERIA
- Alcohol Abstinence Verification: Confirm zero consumption of wine, beer, spirits, or ethanol-containing over-the-counter elixirs within the past 24 hours. Co-ingestion exponentially raises fatal respiratory depression risks.
- Concurrent Opioid Assessment: Ensure no simultaneous dosing with prescription opioids (oxycodone, hydrocodone, tramadol, codeine) unless specifically authorized under dual-prescribing protocols with an active naloxone rescue kit on hand.
- Respiratory Function Check: Withhold administration and seek immediate medical evaluation if experiencing acute respiratory distress, severe sleep apnea hypopnea, or COPD exacerbation.
- Motor Vehicle & Machinery Clearance: Confirm that no driving, hazardous equipment operation, or critical decision-making is scheduled for at least 8 to 12 hours post-dose.
- Safe Storage & Child Resistance: Verify that medication is stored in its original labeled container inside a locked medicine cabinet at controlled room temperature (20°C to 25°C / 68°F to 77°F), completely out of reach of children and pets.
09. Verified Pharmaceutical Formulations & Prescribing Profiles
PRESCRIPTION REQUIRED (Rx)
Authentic Alprazolam Formulations Dispensed by Licensed US Pharmacies
Patients holding an authorized clinical prescription can review authentic manufacturer blister packaging, batch testing verification, and safety monographs for genuine oral formulations:
10. Frequently Asked Questions
Can a 2mg Xanax bar be broken into smaller doses?
Yes. Authentic 2mg bars are multi-scored with three indentations, allowing patients to accurately break the bar into four 0.5mg quadrants as directed by their prescriber.
What should I do if a pill crumbles in my hand or looks chalky?
Never ingest a crumbling, chalky, or irregular tablet. Counterfeit pills pressed in illicit pill presses lack pharmaceutical binding integrity and frequently contain lethal quantities of fentanyl.
11. Clinical References & Regulatory Sources
- U.S. Drug Enforcement Administration (DEA). One Pill Can Kill: Fake Prescription Pills Alert. DEA One Pill Can Kill Campaign.
- U.S. National Library of Medicine. DailyMed Alprazolam Tablet Identification Gallery. NLM DailyMed Gallery.
Consult a Clinical Pharmacy Specialist
Have questions regarding Alprazolam (Xanax / Kaslol) dosing intervals, CYP enzyme interactions, or physician-guided discontinuation protocols? Connect with our licensed clinical pharmacy team for patient safety guidance.
Related Patient Services & Verified Care
Every prescription order is verified by a licensed pharmacist in strict adherence to FDA BeSafeRx protocols.